UPDATE 1-MAP Pharma files marketing application for migraine drug

patients * Says treated nearly 10,000 migraines in a year (Follows alert) n"May 26 (Reuters) - MAP Pharmaceuticals Inc has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for its experimental acute migraine drug. Allergan...